Enanta Pharmaceuticals
ENTA
#8622
Rank
NZ$0.46 B
Marketcap
NZ$15.82
Share price
-18.56%
Change (1 day)
-30.24%
Change (1 year)

EPS for Enanta Pharmaceuticals (ENTA)

EPS in 2026 (TTM): NZ-$4.19

According to Enanta Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$4.39. In 2025 the company made an earnings per share (EPS) of NZ-$5.82 an increase over its 2024 EPS that were of NZ-$9.01.

EPS history for Enanta Pharmaceuticals from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$4.19-28.08%
2025NZ-$5.82-35.35%
2024NZ-$9.01
2021NZ-$9.0672.92%
2020NZ-$5.24-267.44%
2019NZ$3.13-61.35%
2018NZ$8.10147.22%
2017NZ$3.28-460%
2016NZ-$0.91-114.88%
2015NZ$6.12-23.81%
2014NZ$8.03-244.12%
2013NZ-$5.57

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.16-377.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$9.56-317.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
NZ$10.65-342.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$28.52-750.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$1.81-141.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.23-287.55%๐Ÿ‡บ๐Ÿ‡ธ USA